Latest updates for Aml Operations
Fresh curated links around AML operations are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Allogene Therapeutics, Inc. (ALLO) Discusses Interim Futility Analysis from Pivotal Phase II ALPHA 3 Trial in First-Line
- AMLA issues reporting package for the identification of provisionally eligible obliged entities
- HPM’s Allyson Mullen and Jeff Gibbs to Speak at AMDM’s Annual Meeting
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
AMLA issues reporting package for the identification of provisionally eligible obliged entities
On 12 May 2026, the EU Anti-Money Laundering Authority (AMLA) published a reporting package that sets out reporting instructions for Member State supervisors to use in order to ide...
HPM’s Allyson Mullen and Jeff Gibbs to Speak at AMDM’s Annual Meeting
On April 22 and 23, 2026, the Association of Medical Diagnostic Manufacturers will hold its Annual Meeting at the Canopy by Hilton in Bethesda, MD. The day and a half meeting, whi...
AMLA consults on group-wide requirements and business-wide risk assessment
On 16 April 2026, the Anti-Money Laundering Authority (AMLA) issued two consultations on draft instruments that establish how obliged entities should identify, assess, and manage m...
Reframing the AML (Anti-Money Laundering) problem
In a money laundering network, money doesn’t move in neat, traceable lines. It hops across accounts, institutions, and jurisdictions.Continue reading on Medium »
Allogene: Early ALPHA3 Data Suggests Potential Paradigm Shift For Cema-Cel In LBCL
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.